% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • laker9029 laker9029 Apr 9, 2014 11:39 AM Flag

    Positive Cash flow in 2014

    My post on this topic has apparently been censored.

    Bottom line the long term and strengthening Rx trend exclusive of all else (BelPhen, new approvals, etc) and high satisfaction levels (Per WebMD, Drugsdotcom, et al) and the lack of any meaningful competition in a huge market insure that Belviq nRx will be at 26,000 in 6 months and 71,000 in 1 year.

    Arena will be generating positive cash flow.

    SP will be $16-$20.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Wall Street rewards a good balance sheet with profits, cash flow, year over year growth potential, and no debt .......ARNA has all these ingredients cooking on the stove and the pot is starting to boil with new markets on the horizon providing significant growth numbers for 2015 and beyond. Risk is present now for a short term trader, but the upside is huge for a long position.

1.75+0.13(+8.02%)May 27 4:00 PMEDT